[
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=90f898e5a3fd3950d257e9bce46fb37ca353da19602faa5533cd397a981251ad",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736268120,
      "headline": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors",
      "id": 132325185,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=90f898e5a3fd3950d257e9bce46fb37ca353da19602faa5533cd397a981251ad"
    }
  },
  {
    "ts": null,
    "headline": "Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)",
    "summary": "Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects for 2025.",
    "url": "https://finnhub.io/api/news?id=f1588fec1459d5307c6fb14d2a4090f5abed15b46fc8ab0d4ba8d1e2024cdad0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736249479,
      "headline": "Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)",
      "id": 132302431,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1403479106/image_1403479106.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects for 2025.",
      "url": "https://finnhub.io/api/news?id=f1588fec1459d5307c6fb14d2a4090f5abed15b46fc8ab0d4ba8d1e2024cdad0"
    }
  },
  {
    "ts": null,
    "headline": "Poolbeg and Hookipa deal gets support from major stakeholder",
    "summary": "Poolbeg Pharma PLC - London-based clinical stage biopharmaceutical firm - Confirms that Gilead Sciences Inc, a significant shareholder in Hookipa Pharma Inc, intends to vote in line with the Hookipa...",
    "url": "https://finnhub.io/api/news?id=03e8fd9967368b186bb53a8d347e0a02803bc48a7e2e38c928b5bd20093b01fe",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736239932,
      "headline": "Poolbeg and Hookipa deal gets support from major stakeholder",
      "id": 132300019,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Poolbeg Pharma PLC - London-based clinical stage biopharmaceutical firm - Confirms that Gilead Sciences Inc, a significant shareholder in Hookipa Pharma Inc, intends to vote in line with the Hookipa...",
      "url": "https://finnhub.io/api/news?id=03e8fd9967368b186bb53a8d347e0a02803bc48a7e2e38c928b5bd20093b01fe"
    }
  }
]